Ladys Companion To Menopause Treated Naturally (Ladys Companion Series)
The teas have between 3 and 10 mg of THC. THC — or Tetra-hydro-cannabinol — is what gets people high. The other key substance in marijuana is Cannabidiol, or CBD — sometimes recommended to help with pain or inflammation. A small trial recently conducted at the Institute of Psychiatry in London found this substance acts as an anti-psychotic and might counteract some of the negative effects of THC.
It does do the job, at least for me. With the same partner. Beyond California, 28 other states already allow the medical use of marijuana. Some surveys show that opioid use and mainstream medicine prescriptions have fallen in those states, as Americans seek more affordable alternatives for their ailments. But do medical researchers have conclusive evidence of its efficacy?
I met with Professor Westley Clark , an expert in psychotic substances and behavioral health at Santa Clara University. We need more evidence. So just how safe is it? And what about addiction and overdosing? Marijuana can be addictive. It has low addiction potential, there are people who develop dependent syndrome, people who take it daily. Can someone say marijuana is absolutely safe? Is it safe for most people most of the time?
As for other risks, Professor Clark reminds us that tea — and other marijuana edibles — avoid the impact that smoking a joint or vaping has on the heart and lungs. Although the cancer was only in one breast, she opted for a double mastectomy and chose not to reconstruct. She was diagnosed with breast cancer a second time a year later in During her treatment, she searched for a memoir where the narrator grappled with the reality of the disease, where she unpacked questions about reconstruction, and challenged the tacit assumptions about what women want or need to feel whole after cancer.
In this role she helps identify the unmet needs of cancer survivors, as well as late- and long-term effects of treatment. She also oversees the creation of survivorship care plans to meet the long-term needs of survivors. October 5, Michael Stubblefield, M. He is known around the world for his expertise in the identification, evaluation, and rehabilitation of pain and functional disorders caused by cancer and cancer treatments, particularly problems caused by radiation and chemotherapy.
Stubblefield is an accomplished researcher and has published extensively on medical rehabilitation, oncology, pain management, palliative care, and neurophysiology. August 8, Michael Stubblefield, M. July 6, Michael Kovarik is a retired elementary school teacher who is living with metastatic breast cancer. He was also one of the people profiled in Breast Cancer: A Story Half Told, a campaign to increase public awareness of metastatic breast cancer.
June 11, Dr. Frank DellaCroce, or "Dr. D" as he has come to be known, is a founding partner of the Center for Restorative Breast Surgery and St. Charles Surgical Hospital in New Orleans. Board-certified in plastic surgery, Dr. D has performed thousands of reconstructive procedures, both for women diagnosed with breast cancer and women at high risk of the disease who choose to have prophylactic breast removal.
He also has been named one of the "Best Doctors in America. May 18, Dr. His research has been presented at the San Antonio Breast Cancer Symposium, the world's largest scientific meeting on breast cancer. April 17, Dr. Levi Garraway, senior vice president of oncology development and medical affairs at Eli Lilly and Company, discusses some of the research highlights at the AACR Annual Meeting, particularly those in breast cancer.
April 17, Sheila McGlown, who was diagnosed with metastatic breast cancer 5 years after her mother died of the disease, talks about her work with the Shades of Brown Foundation to advocate for, educate, and support African American women diagnosed with breast cancer.
How to turn back the clock on your sex drive after 35
April 16, Dr. Since , he has been a codirector of the San Antonio Breast Cancer Symposium, the world's largest conference focusing entirely on breast cancer. His own research focuses on improving the effectiveness of hormonal therapy medicines and targeted therapies that treat HER2-positive disease. A cancer biologist, her broad research focuses on the interface of basic biology, targeted medicines, and drug resistance. At the American Association for Cancer Research Annual Meeting, she presented research looking at how acquired HER2 mutations can make some metastatic hormone-receptor-positive breast cancers resistant to hormonal therapy.
April 15, Artist Kathryn Stella, vice president of the Bodice Project , discusses how the sculptural exhibit promotes inner healing among women and men who have been diagnosed with breast cancer. April 11, Dr. Dawn Hershman is professor of medicine and epidemiology at Columbia University. She also serves as leader of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia and is nationally recognized for her expertise in breast cancer treatment, prevention, and survivorship.
A member of the Breastcancer. Hershman also has conducted extensive research on breast cancer treatment and quality of life -- she has published more than scientific papers and has received the Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology and the Advanced Medical Achievement Award from the Avon Foundation. Hershman is also on the editorial board of the Journal of Clinical Oncology and is an associate editor at the Journal of the National Cancer Institute.
April 10, Dr. Jennifer Litton is a board certified medical oncologist and associate professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston.
Her research focuses on the genetics of breast cancer and how the genes of a breast cancer change at the molecular level. April 5, Dr. Alexander Miller is a surgical oncologist who specializes in treating breast cancer and people at high risk of the disease. Miller has received awards for excellence in research, education, and patient care.
He has been lead or collaborating researcher for several studies on breast cancer treatments, prevention, genetic testing, and the psychosocial experiences of people receiving cancer care. March 28, Dr. Sherene Loi is a medical oncologist who specializes in treating breast cancer. Much of her clinical research focuses on investigating new treatments, such as immunotherapy, especially for breast cancers that have become resistant to standard treatments. March 26, Dr.
A medical oncologist, Dr. Pluard specializes in offering comprehensive care, including treatments that use advanced genomics and immunotherapy to women diagnosed with metastatic breast cancer. He also incorporates nutrition planning, spiritual counseling, exercise physiology, massage, yoga, palliative care, and emotional support into patient care. He also advises patients on participating in clinical trials on leading-edge treatments for advanced-stage breast cancer.
In the wake of the March 6, U. March 2, Beth Fairchild was diagnosed with de novo metastatic breast cancer in at age The diagnosis was a surprise to her because her mammogram results from the month before were negative and she had never had a lump in her breast. Beth was familiar with breast cancer though. Her mother was diagnosed with breast cancer at age 44 and her paternal grandmother died from breast cancer at age An artist and tattoo professional, Beth and her husband own five tattoo studios. Her focus is on permanent cosmetics, scar camouflage and areola restoration for people diagnosed with breast cancer.
Beth is the current president of METAvivor, a non-profit organization dedicated to increasing awareness of metastatic breast cancer and funding research on metastatic disease. Beth tattoos permanent cosmetics, such as eyebrows or eyeliner, as well as nipples and areolas for women who have had breast cancer surgery. Listen to Beth's podcast about the Serenity Project. February 26, Beth Fairchild was diagnosed with de novo metastatic breast cancer in at age The diagnosis was a surprise to her because her mammogram results from the month before were negative, and she had never had a lump in her breast.
Wiping Away Fatigue — Ayurvedic Tips for Increased Energy : Energy | Maharishi Ayurveda
Her mother was diagnosed with breast cancer at age 44, and her paternal grandmother died from breast cancer at age Her focus is on permanent cosmetics, scar camouflage, and areola restoration for people diagnosed with breast cancer. Beth is the current president of METAvivor , a nonprofit organization dedicated to increasing awareness of metastatic breast cancer and funding research on metastatic disease.
Beth also is one of the creators of the Serenity Project , a metastatic breast cancer support campaign that gives patients an opportunity to tell their personal metastatic breast cancer stories through a series of photos and videos. December 15, Dr. She received her medical degree from the NYU School of Medicine and has been in practice for more than 20 years. December 8, Research has shown that women who are overweight or obese have a higher risk of breast cancer, especially after menopause.
Still, research results have been mixed on whether losing weight would decrease a postmenopausal woman's breast cancer risk. Rowan Chlebowski, research professor in the Department of Medical Oncology and Therapeutics Research at City of Hope, discusses an analysis of data from the very large Women's Health Initiative Observational Study that found that overweight or obese postmenopausal women who lost just a modest amount of weight -- as little as 10 or 15 pounds -- had a lower risk of breast cancer.
December 8, Preserving fertility after chemotherapy is an important issue for many, many younger women diagnosed with early-stage breast cancer. Matteo Lambertini, medical oncologist at the Institute Jules Bordet Brussels, presented research at the San Antonio Breast Cancer Symposium showing that ovarian suppression with a gonadotropin-releasing hormone analogue such as Lupron, Trelstar, or Zoladex, can safely protect ovarian function and may help preserve fertility in younger women being treated with chemotherapy for early-stage disease.
December 8, Joint pain is one of the most common side effects of aromatase inhibitors and may be a big reason why women stop taking these medicines early. December 7, Terry Lynn Arnold, founder of The IBC Network Foundation who was diagnosed with triple-negative inflammatory breast cancer in , talks about how her organization is raising awareness of and funding research on this rare type of breast cancer. Here she talks about how empowering it was to participate in the ThisIsMBC Serenity Project , which gives women and men living with metastatic breast cancer an opportunity to tell their personal stories through a series of unique pictures and inspiring videos.
December 6, The targeted therapy Kisqali chemical name: October 18, A former first grade teacher, Peggy Johnson was diagnosed with breast cancer in November after she became concerned about some dimpling in her left breast. She had six rounds of chemotherapy, then a double mastectomy with immediate implant reconstruction in May She then had radiation therapy.
After that treatment was completed, she had new implants inserted in December In early , at her annual exam with her breast surgeon, the surgeon discovered that one of her implants had ruptured and was leaking. Peggy was told she would have to have her implants replaced yet again. Instead, she decided to have DIEP flap reconstruction as well as nipple reconstruction and nipple tattooing in May Peggy is one of three women whose stories are featured in the Breastcancer. October 5, Breast cancer was familiar to Mimi, even before she was diagnosed.
Her mother has been diagnosed with breast cancer three times. She was treated with a double mastectomy, radiation and chemotherapy. Fifteen years later, she is cancer-free. Mimi herself was diagnosed with stage I breast cancer in April at age 45, the same age her mother was first diagnosed. She had a double mastectomy with immediate DIEP flap reconstruction. Later she also had a preventive hysterectomy because the cancer was hormone-receptor-positive. She took tamoxifen and an aromatase inhibitor but has since stopped. Mimi is one of three women whose stories are featured in the Breastcancer.
October 2, A former pharmaceutical sales rep, Deidra is a 3-time cancer survivor. She was diagnosed with melanoma in at age 32 in In , she was diagnosed with non-Hodgkin lymphoma at age Three days before Christmas in and 12 weeks before the wedding of her son, Pierce, she was diagnosed with hormone-receptor-positive breast cancer in two spots. She also had nipple reconstruction and tattooing. She continues to take an aromatase inhibitor.
Deidra is one of three women whose stories are featured in the Breastcancer. She had no previous diagnosis of cancer. Since her initial diagnosis, the cancer has spread further into her bones and to her liver, despite surgery, various hormonal therapies, and chemotherapy. Krista lives in Ontario, Canada and is married to Patrick, the love of her life. She is the mother of Ethan, who is 16, and Naomi, who is September 21, Dr.
July 31, For nearly 25 years, Kelly Grosklags has dedicated her practice to minimizing suffering through her work in oncology, palliative care and hospice. An experienced therapist, Kelly is a licensed clinical social worker and a board-certified diplomat in clinical social work. She also earned a fellowship in grief counseling from the American Academy of Health Care Professionals. Kelly speaks frequently about end-of-life issues, including care, grief and loss, both in person and on her website, Conversations With Kelly.
Her passionate and supportive demeanor helps patients, caregivers and health professionals connect with the wisdom of making life more meaningful, coping with depression and anxiety, transforming fear into hope, healing versus curing, and the wisdom of dying a good death. July 24, Beth Baughman DuPree performs breast cancer surgery and is vice president at the Holy Redeemer Health System, as well as an adjunct assistant professor of surgery at the University of Pennsylvania.
She is a board certified general surgeon specializing in diseases of the breast. She also has obtained dual board certification in integrative and holistic medicine. She has won numerous awards for her medical work as well as her humanitarian endeavors. These podcasts, along with all the other vital content and community support at Breastcancer.
July 14, For nearly 25 years, Kelly Grosklags has dedicated her practice to minimizing suffering through her work in oncology, palliative care and hospice. May 30, Teva Harrison is an artist, writer, and cartoonist who was diagnosed with stage IV breast cancer at age She is the author of the bestselling, critically acclaimed graphic memoir, In-Between Days ; the book was shortlisted for the Governor General's Literary Award for Non-Fiction. March 24, Ann Partridge, M.
She is a medical oncologist focusing on the care of women with breast cancer and has a particular interest in the psychosocial, behavioral and communication issues in breast cancer care and treatment.
Partridge is also the lead investigator of the U. This study is looking at whether premenopausal women diagnosed with hormone-receptor-positive disease who stop taking hormonal therapy after about 1. Most women diagnosed with hormone receptor positive disease take hormonal therapy for 5 to 10 years after surgery.
In the POSITIVE trial, the women who want to get pregnant are stopping hormonal therapy for up to 2 years to become pregnant, deliver the baby and breastfeed. The women then start hormonal therapy again. If you are a premenopausal woman who has been diagnosed with hormone-receptor-positive breast cancer and have been taking hormonal therapy medicine for fewer than 2 years and are interested in participating in the study, visit the ClinicalTrials.
You also can call Dr. March 8, Dr. He has several active research projects on ways to increase minority and underserved population representation in clinical trials. He also studies state-of-the art cancer treatments, including biosimilars. February 10, Sage Bolte is executive director of Life With Cancer and also serves as associate director of psychosocial program for the Inova Health System.
She is an internationally recognized educator and speaker on sexual health, intimacy, and relationships among people diagnosed with cancer and other chronic diseases. She conducts lectures, workshops, and training to both patient and healthcare professional groups on the topic of the sexual self and cancer survivorship. Her goal is to help empower patients to reclaim their sexual selves in spite of the many physical and emotional changes they may experience from their cancer diagnosis and to help healthcare professionals feel more comfortable and knowledgeable to assess and address the sexual health needs of their patients.
December 10, Breastcancer. December 10, Leah Eshraghi, director of clinical research at the Dr. Susan Love Research Foundation, discusses the poster she presented on quality of life and disease collateral damage in women diagnosed with metastatic breast cancer. December 9, The experimental medicine buparlisib helps treat metastatic hormone-receptor-positive, HER2-negative breast cancer that has been treated with an aromatase inhibitor, but grew after being treated with Afinitor chemical name: December 9, "I've been on a roll of male breast cancer advocacy. In this mini podcast, he talks about his diagnosis and how he works to raise awareness that men can be breast cancer patients, too.
December 9, Breastcancer. December 8, Several studies have shown that cooling the scalp to a very low temperature can help reduce hair loss due to chemotherapy treatment for breast cancer. In this podcast, Julie Nangia, M. Food and Drug Administration clearance.
- Why I'm having my first baby at 51 | Life and style | The Guardian.
- Amazing Calendar Math Magic.
- Leaving for Detroit: and other Stories;
- Insiders Guide to Portland, Oregon, 6th: Including the Metro Area and Vancouver, Washington (Insiders Guide Series)?
This means the system can be marketed in the United States. December 8, "An exciting but early time. Oncologist Philomena McAndrew talks about the exciting, but still early research on what's called by a variety of names: December 7, In , research results showed that taking the hormonal therapy tamoxifen for 10 years instead of 5 offered more benefits for women diagnosed with early-stage, hormone-receptor-positive breast cancer, including less recurrence and better overall survival.
Since that time, researchers have wondered if extending the time a woman with early-stage, hormone-receptor-positive disease took an aromatase inhibitor would offer similar benefits. November 2, In August , Stephen Sala found a small lump on the right side of his chest. His doctor thought it was a cyst, but scheduled an ultrasound to be sure. His ultrasound results were concerning, so he had a mammogram the same day, followed a needle biopsy about a week later. The results showed breast cancer.
He decided to have a bilateral mastectomy to reduce his risk of contralateral disease; pathology results showed that he had cancer in his left chest as well. As he went through diagnosis and treatment, Steve experienced a number of awkward situations. Forms asked when he had his last period, how many children he had given birth to, and if he was in menopause. September 9, Mandi Seifert was 3 when her mother was diagnosed with breast cancer in Mandi knew that meant she had a chance of having the same mutation. In , she decided to have genetic testing and learned that she, too, had a BRCA2 mutation.
She decided to have a double prophylactic mastectomy and reconstruction using tissue from her tummy area. Mandi is one of three women whose stories are featured in the Breastcancer. September 8, Kerry Osmond was 10 when her mother was diagnosed with breast cancer in Kerry knew that meant she had a chance of having the same mutation.
She decided to have a double prophylactic mastectomy and reconstruction using tissue from her hip area. Kerry is one of three women whose stories are featured in the Breastcancer. September 6, Lorell Hornbrook has a strong family history of breast cancer: Both her older sister and her father were diagnosed with breast cancer.
1 599,60 RUB
Her father died at age 75 from treatment complications, a year after he was diagnosed. In , at age 48, Lorell decided to have genetic testing to see if she had a gene mutation that dramatically increased her risk for breast cancer. When her test results came back positive for a BRCA2 mutation, Lorell had already decided what she would do: Lorell is one of three women whose stories are featured in the Breastcancer.
He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation. May 11, Dr. Listen to part 2 of the series. This is part three of three-part podcast on genetics and breast cancer with Cristina. Listen to this podcast to hear her explain:. Listen to part 1 of the series.